Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04364945
Other study ID # H2003-234-1115
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date June 17, 2020
Est. completion date December 30, 2028

Study information

Verified date April 2023
Source Seoul National University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, we compared the results of the intelligence and behavioral test performed after surgery between the group using sevoflurane and the group receiving dexmedetomidine and remifentanil, in Korean children under 2 years of age who underwent surgery under general anesthesia.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 400
Est. completion date December 30, 2028
Est. primary completion date May 30, 2028
Accepts healthy volunteers No
Gender All
Age group N/A to 23 Months
Eligibility Inclusion Criteria: - Children under 2 years of age who underwent general anesthesia for elective surgeries of urology, surgery, plastic surgery, orthopedics, and otolaryngology - American Society of Anesthesiology Physical Status I, II Exclusion Criteria: - Allergies to narcotic analgesics - With massive bleeding or shock - Heart, lung, kidney or liver disease - Central / peripheral nervous system disease and disorder - Any physical deformity and disorder, genetic disease, chromosomal disease - Previous history of general anesthesia or sedation - Additional exposure to general anesthetics or sedative drugs during follow-up

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
dexmedetomidine
administration of dexmedetomidine 1 mcg/kg/hr
remifentanil
administration of remifentanil 0.1-0.2 mcg/kg/min
Sevoflurane
Anesthesia is maintained using sevoflurane.

Locations

Country Name City State
Korea, Republic of Seoul National University Hospital Seoul Other

Sponsors (1)

Lead Sponsor Collaborator
Seoul National University Hospital

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Wechsler Preschool and Primary Scale of Intelligence-IV at age of 5 When the patient's age is 5 years after surgery
Secondary Leiter International Performance Scale at age of 2 When the patient's age is 2 years old after surgery
Secondary Wechsler Preschool and Primary Scale of Intelligence-IV at age of 7 When the patient's age is 7 years old after surgery
Secondary Child Behavior Checklist results Child Behavior Checklist results at age of 2, 5, 7 When the patient's age is 2, 5 and 7 years old after surgery